SCHEMBL1660636

SCHEMBL1660636

CC1(C)CCCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18029933 1.00
SCHEMBL17971806 1.00
SCHEMBL4988233 0.92
SCHEMBL12536749 0.92
Hydrochloric Acid SCHEMBL27949555 0.89 GAA (0.38)
Acetic Acid SCHEMBL27831209 0.81 UGT2B7 (0.35)
SCHEMBL1380363 0.78 CYP3A4 (0.41)
SCHEMBL26088608 0.78
SCHEMBL13625216 0.78
SCHEMBL1382052 0.76 CA1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103201243-B Process for the preparation of 5- [1- (4-chlorophenyl) -methylene ] -1-hydroxymethyl-2, 2-dimethyl-cyclopentanol BASF SE 2015-02-25 CN claimed
EP-4143179-B1 AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER IDORSIA PHARMACEUTICALS LTD (CH) 2025-10-22 EP disclosed
US-20250320207-A1 Ketal Protected Intermediate for Sonrotoclax and Preparation Method Thereof BEONE MEDICINES I GMBH (CH) 2025-10-16 US disclosed
EP-4551571-A1 OXAZOLE TRPML1 AGONISTS AND USES THEREOF Libra Therapeutics, Inc. (US) 2025-05-14 EP disclosed
CN-119790050-A Oxazole TRPML1 agonists and uses thereof 利布拉医疗公司 2025-04-08 CN disclosed
US-12098145-B2 Oxazole TRPML1 agonists and uses thereof LIBRA THERAPEUTICS, INC. (US) 2024-09-24 US disclosed
EP-4376955-A1 PHENYL-SULFAMOYL-BENZOIC ACID DERIVATIVES AS ERAP1- MODULATORS Grey Wolf Therapeutics Limited (GB) 2024-06-05 EP disclosed
US-20240158381-A1 OXAZOLE TRPML1 AGONISTS AND USES THEREOF LIBRA THERAPEUTICS, INC. 2024-05-16 US disclosed
WO-2024011155-A1 OXAZOLE TRPML1 AGONISTS AND USES THEREOF LIBRA THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS, SAN DIEGO 2023-11-23 US disclosed
CN-102015985-B Perfume GIVAUDAN SA 2013-04-17 CN disclosed
US-8377458-B2 Cooling sensation agent composition, sensory stimulation agent composition and use of the same TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-02-19 US disclosed
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-05-19 US disclosed
CN-102015985-A Perfume GIVAUDAN SA 2011-04-13 CN disclosed
US-20110081393-A1 COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME TAKASAGO INTERNATIONAL CORPORATION 2011-04-07 US disclosed
US-20100317646-A1 COMPOUNDS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2010-12-16 US disclosed
WO-2010122171-A1 5-HETEROARYLMETHYL-I- (B-MERCAPTO- [1,2, 4 -TRIAZOLYLMETHYL) -CYCLOPENTANOL AS FUNGICIDES BASF SE (DE) 2010-10-28 WO disclosed
WO-2009123355-A2 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-10-08 WO disclosed
CN-1313428-C Method for producing carboxylic acid NAT INST OF ADVANCED IND SCIEN (JP) 2007-05-02 CN disclosed
CN-1671642-A Process for producing carboxylic acid NAT INST OF ADV IND & TECHNOL (JP) 2005-09-21 CN disclosed